Global Pediatric Medical Devices Market to Reach US$ 75 Billion by 2032, Bolstered by Increasing Prevalence of Chronic and Infectious Diseases

The latest report by IMARC Group, titled “Pediatric Medical Devices Market Report by Product (IVD Devices, Cardiology Devices, Anesthesia and Respiratory Care Devices, Neonatal ICU Devices, Monitoring Devices, Diagnostic Imaging Devices, Telemedicine, and Others), End User (Hospitals, Diagnostic Laboratories, Pediatric Clinics, and Others), and Region 2024-2032,” finds that the global pediatric medical devices market size reached US$ 38.6 Billion in 2023. Pediatric medical devices refer to equipment used to treat or diagnose diseases and conditions in children from birth to age 21, primarily involving pulmonary, chronic respiratory, and cardiac disorders. Some of the commonly utilized pediatric medical devices include transcutaneous oxygen or carbon dioxide monitors, mechanical ventilators, continuous positive airway pressure tubes, cardiorespiratory monitors, and baby thermometers. These devices are specifically designed to suit the body structures and functions of children as they are younger and more active than adults. As a result, pediatric medical devices are extensively adopted across pediatric clinics, ambulatory surgery centers, hospitals, and research and academic institutes.

Global Pediatric Medical Devices Market Trends:

The market is primarily driven by the rising prevalence of chronic and infectious diseases, such as chickenpox, mumps, pneumonia, tuberculosis, anemia, asthma, measles, whooping cough, Lyme disease, diphtheria, and leukemia among the pediatric population. This has resulted in increased demand for advanced technologies for accurate diagnosis of such conditions, which is contributing to market growth. In addition, the sudden outbreak of coronavirus disease (COVID-19) pandemic has escalated upper respiratory symptoms such as rhinitis, sneezing, nasal congestion, nausea, vomiting, and diarrhea among pediatric patients, which is accelerating the product adoption rate. Moreover, the surging usage of 3D medical imaging equipment in pediatric radiology and the increasing preterm birth rates are also contributing to market growth. Apart from this, various technological advancements and the widespread adoption of portable devices for home healthcare services are providing a positive thrust to market growth. Additionally, the implementation of favorable initiatives undertaken by the governments of various countries, such as the launch of attractive medical reimbursement programs, represents another major growth-inducing factor. Other factors, including the expanding pediatric hospitals across the globe and the rising awareness among parents about pediatric health, are creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 75 Billion by 2032, exhibiting a CAGR of 7.5% during the forecast period (2024-2032).

Market Summary:

• Based on the product, the market has been classified into IVD devices, cardiology devices, anesthesia and respiratory care devices, neonatal ICU devices, monitoring devices, diagnostic imaging devices, telemedicine, and others.
• On the basis of the end user, the market has been segmented into hospitals, diagnostic laboratories, pediatric clinics, and others.
• Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
• The competitive landscape of the industry has also been examined in the report, with some of the key players being Abbott Laboratories, Atom Medical Corporation, Baxter International Inc., Cardinal Health Inc., Fritz Stephan GmbH, General Electric Company, Hamilton Medical (Hamilton Company), Koninklijke Philips N.V., Medtronic plc, Siemens AG, and Stryker Corporation.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800